Revenue

Formerly Hoth Therapeutics, Rocket One is betting its future on novel spintronic computing. A look at the tech, the risks, and the ambitious strategy.

A landmark partnership between US and Indian firms aims to build a massive 1 GW AI data campus in Florida, signaling a strategic shift toward vertically integrated power and compute.

A Swedish startup just raised €3.1M for a novel solar tracker. It’s not just about clean energy; it's a bet on rewriting the rules for half the planet.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

A new report reveals a record 242 US cities have starter homes costing $1M, tripling since 2020. This isn't just a number—it's a fundamental market reset.

Rain's new integrated loyalty platform aims to make stablecoin cards mainstream, offering partners a way to drive engagement and a proven 25% spending lift.

The deal showcases a masterful exit in a tough market and signals deeper shifts in the pharma R&D landscape, where specialized research partners are king.

Aurora Mobile integrates ShengShu's potent Vidu model, a strategic maneuver to challenge giants like OpenAI and Google by offering a unified, production-ready AI video platform.

Zevia PBC appoints beverage industry veteran Alexandre Ruberti as CEO, pivoting from turnaround to 'accelerated execution' at a critical inflection point.

A partnership born from a military hackathon shows how rapid prototyping is shattering old procurement models and accelerating autonomous defense solutions.

Nuvei's acquisition of Payoneer creates a fintech giant, combining payment acceptance and cross-border payouts to challenge rivals and redefine global commerce.

A missed clinical trial endpoint is often the end. For Elicio Therapeutics, a deeper data dive reveals a potential path forward for a high-need patient group.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

With its new Colorado facility, USA Rare Earth aims to produce vital heavy rare earths, a critical step in the West's high-stakes bid to build a secure supply chain.

A green finance firm is investing in gas-powered data centers. Stephen Miller analyzes the $15M deal that reveals the pragmatic, and controversial, future of AI.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

A forum in Xiamen unveils a RMB 9.1 billion push for financial integration, but is it just about business, or a deeper play for Taiwan's future?

Gilat's acquisition of a key Comtech division isn't just a purchase; it's a strategic power play to build a $700M defense tech giant for a new era.

The collateral management firm appoints a new CPO and promotes key execs, signaling a foundational shift to build autonomous AI-native products.